BRIEF-Tibet Aim Pharm says dividend payment date
Reuters SEOUL, June 2 South Korea's Samsung Bioepis Co Ltd is developing a lower-cost copy of Roche Holding AG's eye drug Lucentis, a U.S. filing showed, revealing a previously undisclosed product in the biosimilar maker's pipeline. |
http://ift.tt/2rKRUBH
No comments:
Post a Comment